Company intelligence / Profile preview

MycoForest

United Kingdom

Ownership: Private
Development stage: Other

Overview

MycoForest is a biotechnology company specializing in the research, cultivation, and commercialization of medicinal and gourmet mushrooms. The company focuses on leveraging fungal biology to develop high-quality mushroom-based products, including liquid cultures, spores, and extracts intended for health and wellness applications. By integrating sustainable cultivation practices with scientific research, MycoForest aims to advance the understanding of mycology and its potential in the life sciences sector. Their offerings cater to both individual consumers and research institutions interested in the therapeutic properties of fungi.

Therapeutic areas: ImmunologyOther
Modalities: Fungal extractsMicrobial therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on MycoForest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MycoForest.

Explore the full profile